December, 2017

The Strata Data Conference began in 2012 and has grown to be one of the largest and most popular data conferences in the world. Topics include artificial intelligence, machine learning, ubiquitous computing, and machine data. Ayin Vala, Co-Founder and Chief Data Scientist of the Foundation for Precision Medicine and Senior Data Scientist at Apri Health, traveled to New York City to present the Foundation’s ongoing research on using machine learning to predict Alzheimer’s dementia. Ayin describes this research:

Complex disease processes like Alzheimer’s Disease cannot be cured by pharmaceutical or genetic sciences alone and current treatments and therapies lead to mixed successes. By introducing more data-driven investigation we can take into account individual variability in medicine intake, lifestyle, and genetic factors for each person and use the power of big data and artificial intelligence to treat challenging diseases.

The Foundation was created to create a collaborative platform to address patients’ unmet needs, and this pilot project, performed in collaboration with Apri Health, is a testament to this initiative. In fact, Apri Health is a proud recipient of National Institute of Aging’s Small Business Innovation Research (SBIR) Phase I grant to study Alzheimer’s Disease patients at high risk of hospitalization, using medication regimens, comorbidities, risk factors, and care programs. The Foundation’s contribution at the Strata Data Conference highlights a few of our machine learning projects in personalized medicine, leading to better care for patients and cost saving for hospitals.

Apri Health Data Scientist Ayin Vala